A-shares closed · 港股休市 Quotes 行情 · 28 Sep 20:16 CST
29 Sep 2026 · 01:44 CST Terminal Access 终端入口 →
688317.SH上海证券交易所 · 科创板 STAR

Shanghai ZJ Bio-Tech 之江生物

Medical Devices 医疗器械
¥18.24−¥0.51 · −2.72%Delayed 行情延迟 · 28 Sep 2026 · 16:14 CST · CNY
Open 开盘
¥18.64
High 最高
¥19.00
Low 最低
¥18.15
Prev Close 昨收
¥18.75
Volume 成交量
361.1万股
Turnover 成交额
¥6,642.3万
Mkt Cap 总市值
¥35亿
P/E 市盈率
−53.2×
Recent Activity 近期动态All Filings 全部公告 →

9 significant filings since 1 Jun 2026: 3 on regulatory inquiry and 6 on buyback. The latest, on 2 Sep 2026: 之江生物:关于2025年第三次以集中竞价交易方式回购公司股份的进展公告.
自 1 Jun 2026 起有 9 份重大公告:regulatory inquiry 3 份、buyback 6 份。最新一份(2 Sep 2026):之江生物:关于2025年第三次以集中竞价交易方式回购公司股份的进展公告。

Price History 价格走势

5 sessions 个交易日, 21 Sep to 28 Sep 2026 · Live one-minute prices 实时分钟价格 · High 最高 ¥19.80 · Low 最低 ¥16.41 · −2.72% on the previous close of ¥18.75 较昨收 · 30-minute candles from each minute's last price 30分钟K线,由每分钟最新价合成
16.5017.0017.5018.0018.5019.0019.50
Volume 成交量
388.4万
21 Sep22 Sep23 Sep24 Sep28 Sep

Against Its Own History 与自身历史比较

−53.2×
Median 中值 11.5× · Range 区间 8.5× to 27.7× · 9 periods 期
1.07×
Median 中值 1.14× · Range 区间 0.73× to 2.63× · 20 periods 期

Period by Period 逐期

Period 报告期Close at Period End 期末收盘TTM EPS 滚动每股收益 BPS 每股净资产
30 Jun 2026 中报¥15.20−¥0.37—¥16.970.90×
31 Mar 2026 一季报¥18.88−¥0.26—¥17.191.10×
31 Dec 2025 年报¥20.17−¥0.19—¥17.431.16×
30 Sep 2025 三季报¥23.23−¥0.76—¥17.661.32×
30 Jun 2025 中报¥18.02−¥0.86—¥17.931.00×
31 Mar 2025 一季报¥17.16−¥0.89—¥18.380.93×
31 Dec 2024 年报¥16.25−¥0.67—¥18.930.86×
30 Sep 2024 三季报¥18.21−¥0.96—¥19.640.93×
30 Jun 2024 中报¥14.41−¥0.74—¥19.620.73×
31 Mar 2024 一季报¥15.89−¥0.60—¥19.720.81×
31 Dec 2023 年报¥20.98−¥0.71—¥19.641.07×
30 Sep 2023 三季报¥23.02¥0.8327.7×¥20.521.12×
30 Jun 2023 中报¥23.70¥1.6514.4×¥20.541.15×
31 Mar 2023 一季报¥31.32¥2.5512.3×¥21.591.45×
31 Dec 2022 年报¥33.40¥3.938.5×¥21.571.55×
30 Sep 2022 三季报¥34.92¥4.088.6×¥20.921.67×
30 Jun 2022 中报¥37.39¥4.368.6×¥20.451.83×
31 Mar 2022 一季报¥41.66¥3.6211.5×¥21.031.98×
31 Dec 2021 年报¥51.64¥3.9813.0×¥19.662.63×
30 Sep 2021 三季报¥47.25¥4.809.8×¥18.832.51×

Consensus Forward EPS 机构预测每股收益

No broker forecasts for this company yet 暂无机构预测

Not Computed 未计算
  • Dividend Yield 股息率
  • Free Cash Flow 自由现金流
  • EV/EBITDA